United Therapeutics Corporation shares owned by Assetmark
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Assetmark
from 13F filings
Historical chart of Assetmark investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Assetmark consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by Assetmark
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $271M | 646k | 419.21 |
| 2025-06-30 | $206M | 716k | 287.35 |
| 2025-03-31 | $160M | 519k | 308.27 |
| 2024-12-31 | $151M | 429k | 352.84 |
| 2024-09-30 | $151M | 420k | 358.35 |
| 2024-06-30 | $85M | 268k | 318.55 |
| 2024-03-31 | $62M | 270k | 229.72 |
| 2023-12-31 | $60M | 272k | 219.89 |
| 2023-09-30 | $61M | 270k | 225.87 |
| 2023-06-30 | $62M | 282k | 220.75 |
| 2023-03-31 | $61M | 270k | 223.96 |
| 2022-12-31 | $67M | 240k | 278.09 |
| 2022-09-30 | $56M | 266k | 209.38 |
| 2022-06-30 | $50M | 213k | 235.64 |
| 2022-03-31 | $46M | 257k | 179.41 |
| 2021-12-31 | $56M | 260k | 216.08 |
| 2021-09-30 | $45M | 244k | 184.58 |
| 2021-06-30 | $39M | 215k | 179.41 |
| 2021-03-31 | $32M | 190k | 167.27 |
| 2020-12-31 | $28M | 187k | 151.79 |
| 2020-09-30 | $17M | 170k | 101.00 |
| 2020-06-30 | $8.2M | 71k | 116.04 |
| 2020-03-31 | $9.0k | 97 | 92.78 |
| 2019-12-31 | $3.0k | 34 | 88.24 |
| 2019-06-30 | $18k | 232 | 77.59 |
| 2019-03-31 | $26k | 218 | 119.27 |
| 2018-12-31 | $24k | 218 | 110.09 |
| 2018-09-30 | $79k | 619 | 127.63 |
| 2018-06-30 | $61k | 537 | 113.59 |
| 2018-03-31 | $50k | 449 | 111.36 |
| 2017-12-31 | $62k | 421 | 147.27 |
| 2017-09-30 | $50k | 424 | 117.92 |
| 2017-06-30 | $110k | 853 | 128.96 |
| 2017-03-31 | $67k | 502 | 133.47 |
| 2016-12-31 | $12k | 82 | 146.34 |
| 2016-09-30 | $18k | 148 | 121.62 |
| 2016-06-30 | $20k | 194 | 103.09 |
| 2015-12-31 | $1.0k | 5 | 200.00 |
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation